T. Rowe Price Associates
BNTX icon

T. Rowe Price Associates’s BioNTech BNTX Stock Holding History

T. Rowe Price Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Buy
+161,826
New +$15.2M ﹤0.01% 1225
2025
Q1 		– Sell
-313,789
Closed -$35.8M – 3046
2024
Q4 		$35.8M Sell
313,789
-5,080
-2% -$580K ﹤0.01% 856
2024
Q3 		$37.9M Buy
318,869
+266,667
+511% +$24.5M ﹤0.01% 829
2024
Q2 		$4.2M Sell
52,202
-393
-0.7% -$35.9K ﹤0.01% 1276
2024
Q1 		$4.85M Sell
52,595
-9,562
-15% -$917K ﹤0.01% 1225
2023
Q4 		$6.56M Buy
62,157
+1,544
+3% +$156K ﹤0.01% 1164
2023
Q3 		$6.58M Hold
60,613
– – ﹤0.01% 1132
2023
Q2 		$6.54M Sell
60,613
-300
-0.5% -$33.7K ﹤0.01% 1144
2023
Q1 		$7.59M Sell
60,913
-723,365
-92% -$99.3M ﹤0.01% 1104
2022
Q4 		$118M Sell
784,278
-472,031
-38% -$72.6M 0.02% 464
2022
Q3 		$169M Sell
1,256,309
-591,626
-32% -$90.4M 0.03% 394
2022
Q2 		$276M Buy
1,847,935
+321,110
+21% +$49.1M 0.03% 396
2022
Q1 		$260M Sell
1,526,825
-10,898
-0.7% -$1.83M 0.03% 461
2021
Q4 		$396M Buy
1,537,723
+373,884
+32% +$102M 0.04% 393
2021
Q3 		$318M Sell
1,163,839
-866,822
-43% -$276M 0.03% 435
2021
Q2 		$455M Sell
2,030,661
-44,245
-2% -$8.34M 0.04% 358
2021
Q1 		$227M Buy
2,074,906
+500,085
+32% +$53.1M 0.02% 521
2020
Q4 		$128M Buy
1,574,821
+377,177
+31% +$37M 0.01% 643
2020
Q3 		$82.9M Buy
1,197,644
+900,644
+303% +$64.6M 0.01% 713
2020
Q2 		$19.8M Buy
+297,000
New +$14.8M ﹤0.01% 1150

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

T. Rowe Price Associates's BNTX Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in BioNTech (BNTX) in Q2 2026: 161,826 shares worth $15.1M. The stake represents ﹤0.01% of the portfolio and ranks #1225 among its holdings. This is a return to the name: T. Rowe Price Associates previously reported a position in BNTX as recently as Q4 2024.

T. Rowe Price Associates first reported a position in BNTX in Q2 2020 and has held it in 20 quarters since. The position peaked at $455M in Q2 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • T. Rowe Price Associates held 161,826 shares of BioNTech worth $15.1M as of Q2 2026.
  • BioNTech was a new T. Rowe Price Associates position in Q2 2026.
  • BioNTech made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1225 holding.
  • T. Rowe Price Associates first reported a position in BioNTech in Q2 2020 and has held it in 20 quarters since.
  • T. Rowe Price Associates's BioNTech position peaked at $455M in Q2 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.